EP2371237A1 - Masque facial - Google Patents

Masque facial Download PDF

Info

Publication number
EP2371237A1
EP2371237A1 EP10158628A EP10158628A EP2371237A1 EP 2371237 A1 EP2371237 A1 EP 2371237A1 EP 10158628 A EP10158628 A EP 10158628A EP 10158628 A EP10158628 A EP 10158628A EP 2371237 A1 EP2371237 A1 EP 2371237A1
Authority
EP
European Patent Office
Prior art keywords
segment
face mask
face
cheek
region
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP10158628A
Other languages
German (de)
English (en)
Other versions
EP2371237B1 (fr
Inventor
Anne Hesping
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medskin Solutions Dr Suwelack AG
Original Assignee
Dr Suwelack Skin and Health Care AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Suwelack Skin and Health Care AG filed Critical Dr Suwelack Skin and Health Care AG
Priority to EP10158628.7A priority Critical patent/EP2371237B1/fr
Publication of EP2371237A1 publication Critical patent/EP2371237A1/fr
Application granted granted Critical
Publication of EP2371237B1 publication Critical patent/EP2371237B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A45—HAND OR TRAVELLING ARTICLES
    • A45D—HAIRDRESSING OR SHAVING EQUIPMENT; EQUIPMENT FOR COSMETICS OR COSMETIC TREATMENTS, e.g. FOR MANICURING OR PEDICURING
    • A45D44/00—Other cosmetic or toiletry articles, e.g. for hairdressers' rooms
    • A45D44/002—Masks for cosmetic treatment of the face

Definitions

  • the present invention relates to a flexible mask face mask and a kit-of-parts containing this face mask.
  • Another object of the present invention is a method for producing the face mask according to the invention.
  • the present invention relates to the use of the face mask or the kit-of-parts for the cosmetic treatment and / or for the therapeutic treatment of facial skin areas.
  • Masks, sheets, matrices, overlays, pads, layers or similar flat forms play an important role here.
  • Such embodiments are particularly suitable for the external and surface treatment and care of the skin as well as for the treatment of flat skin injuries or wounds.
  • special, sometimes very specific material and functional requirements are to be imposed on such compositions, in particular on their chemical composition and their physical or biological-chemical action and mode of operation.
  • the complex biochemical interactions and modes of functioning with the organ "skin" have to be considered.
  • the care and the preventive protection by a cosmetic treatment can in particular by the introduction and contribution of active, Nursing and / or care agents are achieved, but also by supporting or improving the physical and mechanical protective and / or barrier properties, such as elasticity, smoothness, roughness, dryness or biochemical balance of the skin.
  • the support, protection, regulation and improvement of the moisture and fat content, in particular the so-called "Natural Moisturizing Factor” (NMF) and the barrier function of the skin is an important treatment element.
  • a treatment of particular importance is one that has a soothing, healing or restorative effect.
  • Such therapeutic treatment may also be by delivery of certain positive-acting active ingredients, curatives or active ingredients or by suitable supporting physical or biochemical methods that support and favorably influence self-healing.
  • the nature and extent of such a therapeutic treatment are dependent in particular on the type of injury or dysfunction and specifically tailored to the affected skin layers.
  • solid, dry or premoistened, absorbent or hydratable preparation forms in particular in the form of flat masks, sheets, pads or pads, is in principle particularly suitable and already widespread for both areas, the nourishing cosmetic and the therapeutic area of the skin treatment ,
  • particularly those preparations are of interest, which in addition to the active ingredient application also have a skin-hydrating and optionally cooling effect in itself. This is equally relevant for cosmetic as well as therapeutic skin treatment.
  • the geometric configurations of the pads are of great importance and must be adapted to the respective body shapes to be treated in order to allow an efficient treatment of the skin.
  • the present invention now relates to the specific technical field of face masks, and more particularly to specific geometric designs of face masks.
  • a face mask in the sense of the present invention is understood to mean a mask which can be applied to at least a partial area of the face, whereby both the face mask itself, that is to say the face mask, are used by the present invention. in a form not applied to a face, as well as the facial mask already applied to a face is understood.
  • a face mask is also understood to mean a mask for treating the human neck. In the context of the present invention, therefore, the neck is defined as belonging to the face.
  • a face mask is also generally understood to mean a special care product which is moistened with warm or cold liquids and can be applied to the skin, in particular to the facial skin, and removed again after a certain exposure time. This is intended to support and supplement general skin care.
  • a face mask which is integrally formed and openings corresponding to the mouth, nose and eyes of the user has.
  • the face mask according to EP 0 063 875 A1 is designed to cover the entire facial area with the one-piece mask.
  • US 5,656,279 is a face mask known, which is integrally formed. Special geometrical embodiments of the face mask are in the US 5,656,279 not described.
  • US 2003/0190339 A1 is a face mask is known, which has in the head area, slightly left and right offset to the line connecting the forehead, nose and chin, wrinkles. This fold structure is used according to the example part of US 2003/0190339 A1 to adjust the size of the face mask to the face to be covered.
  • a disadvantage of these known from the prior art face masks is that they do not allow a satisfactory flexible adaptation to different face shapes and it often comes to the application to a face to wrinkles of the mask or these must be cut before or during the application.
  • the latter is particularly disadvantageous for hygienic and safety reasons, since the use of suitable cutting tools such as scissors or knives increases the potential for contamination with microorganisms introduced thereby or the risk of injury associated with their use.
  • the face masks known in the prior art are not designed so that single facial areas can be treated completely in one piece with a single continuous mask or a single continuous portion of a mask. Also, a specific different treatment of individual parts of the face is not feasible with the face masks of the prior art.
  • the present invention now has the object to solve the disadvantages described above and goes to solve these problems from a face mask (1) made of a flexible carrier material suitable for receiving liquids.
  • the face mask according to the invention is in the FIGS. 1 to 3 , which will be referred to in the following, shown in detail.
  • the face mask is modularly constructed from at least three different regions, namely the front segment (2), the cheek segment (3) and the neck segment (4).
  • the individual regions are interconnected by perforations (5, 6) , so that it is possible to separate the individual segments (2, 3, 4) from each other and to use separately.
  • the modular design of the face mask (1) allows an optimal adaptation of the face mask (1) to different types of face, such as facial skin. As Caucasian, Eurasian or Asian face types, or to the different face shapes, such as round, oval, heart-shaped, square or square face shapes, done as a displacement of the individual segments (2, 3, 4) after their separation is possible.
  • the severing of the perforations (5, 6) and thus a disassembly of the face mask according to the invention in the corresponding segments can be done by simple tearing, eg manually.
  • the segments (2, 3, 4) along the perforations (5, 6) can also be separated with the aid of suitable aids, such as a pair of scissors or a knife.
  • the inventively provided modular construction of the face mask (1) of end segment (2), cheek segment (3) and neck segment (4) allows a different loading of the segments with active ingredients and / or excipients. This is important insofar as the facial skin is known to be in different zones, e.g. the so-called T-zone, U-zone, etc. can be divided, the different zones having a different skin structure or sensitivity with correspondingly different treatment, care or protection requirements.
  • the individual segments (2, 3, 4) of the face mask (1) according to the invention are further designed such that with each segment an integral treatment of the corresponding facial parts is possible.
  • the neck of a human can be completely treated on the front side with the integrally formed neck segment (4).
  • the use of different segments is avoided in the respective parts of the face, which on the one hand facilitates the application of the face mask (1) according to the invention and on the other hand increases the wearing comfort.
  • the cheek segment (3) of the face mask (1) according to the invention is designed so that the cheek segment (2) along the perforation (5) has an arcuate contour which extends at the edge in the direction of the end part (2).
  • the masticatory muscle lies symmetrically in both jaws and has its attachment point on the outside of the cheekbone and runs to the outer jaw angle.
  • the face mask (1) according to the invention is further characterized in particular in that the face mask (1) arranged between the frontal segment (2) and the cheek segment (3) above the cheek segment (3) has two regions (7, 8) which correspond to the two Eye areas correspond to a human face. These regions (7, 8) are preferably connected to one another by perforations (5a, 5b) with the front segment (2) and the cheek segment (3) such that the regions (7, 8) are removed altogether from the face mask (1) according to the invention can.
  • the two areas (7, 8) are designed so that they can be used after the separation from the face mask (1) for the treatment of other skin areas of the human face.
  • the areas below the eyes of a face are particularly suitable. The efficient use of excess mask material can significantly reduce the need to make appropriate face masks.
  • the detachably formed regions (7, 8) can be used both simultaneously with the other segments (2, 3, 4) of the face mask (1) according to the invention or else separately, for example at a later time.
  • the areas (7, 8) are generally of a substantially oval shape, the substantially oval regions (7, 8) extending downwardly to the cheek segment (3) and tapering to the nasal bone of a human face Nasal bone of a human face tapering extensions (22, 23) have.
  • the corresponding mask parts be used very close to the human eye so that the formation of eye wrinkles is effectively treated (cf. FIG. 3 ).
  • the segments (7, 8) have a contour adapted to this requirement.
  • the face mask (1) according to the invention between the end segment (2) and the cheek segment (3) below the end segment (2) arranged on a region (9), which corresponds to the nasal wing region of a human face.
  • This region (9) is connected to one another by perforations (5c, 5d) with the front segment (2) and the cheek segment (3) so that the region (9) can be removed from the face mask (1).
  • the area (9) is preferably designed such that it can be used after being separated from the face mask (1) for a further skin zone of the human face, in particular the glabella area of the human face (cf. FIG. 3 ).
  • the distance a between two horizontal lines (29, 30) which is at the level of the lowest point A of the area (9) and the uppermost points B and B 'of the arch at least 2.5 cm, preferably at least 3, 0 cm, more preferably at least 3.5 cm, more preferably at least 4.0 cm, more preferably at least 4.5 cm, particularly preferably at least 5.0 cm.
  • the face mask (1) according to the invention can be used by as many people as possible with different facial types, it is preferred if the end segment (2) and the cheek segment (3) are designed so that they can be displaced along the vertical course of the human face when applying both segments on the human face, wherein areas of the end segment (2) and of the cheek segment (3) can overlap. For this purpose, a previous separation of the individual segments (2, 3, 4) along the perforations (5, 6) is required.
  • the front part (2) of the face mask (1) according to the invention has a substantially T-shaped structure, which extends in an arcuate manner downwards in the edge region in the direction of the cheek segment (3).
  • the end segment (2) has a region (11) which corresponds to the nasal wing region of a human face, the region (11) widening in the direction of the cheek segment (3).
  • this area is formed as a perforation (20, 21)
  • a special stability of the unused face mask is achieved, and an undesired breakup of the individual segments, in particular of the segments (2, 3), can be prevented.
  • the face mask (1) according to the invention that in the left and / or right edge region (12, 13) of the face mask (1) adjacent to the regions (7, 8) Recesses (14, 15) are present or regions (14, 15) which are connected to the front segment (2) and the cheek segment (3) by edge cuts and / or perforations so that a separation of the regions (14, 15) Forming recesses (14, 15) from the face mask (1) according to the invention is possible.
  • the corresponding areas (14, 15) can thus either be completely removed or the face mask (1) has a perforation with which corresponding recesses (14, 15) can be easily formed.
  • the areas (14, 15) are excluded from the face mask (1) according to the invention, it is easy for the user to separate out the areas (7, 8) which correspond to the eye areas of the human face and which are generally used separately.
  • the recesses (14, 15) or the areas (14, 15) are substantially triangular in shape, wherein it is even more preferable if the substantially triangular recesses (14, 15) or areas (1 4, 15) face outward and taper outwards into a point (16, 17).
  • This also improves the stability of the unused face mask and disassembly of the face mask according to the invention into the individual segments is easily possible.
  • the face mask (1) it is also possible for the face mask (1) to have a point (16, 17) of the recesses (14, 15) or of the areas (14, 15) pointing from the outer edge (18, 19) to the outwardly pointing tip (16, 17) ) reaching edge section (20, 21).
  • the perforation (6) connecting the cheek segment (3) and the neck segment (4) is not continuous to the left and / or right outer edge (18, 19) of the face mask (FIG. 1), but in the left and / or right edge region (12, 13) of the face mask (1) ends and the further course is formed to the right and / or left outer edge of the face mask (1) in the form of one or more edge cuts.
  • the lower edge of the cheek segment (3) formed by such edge cuts and / or the upper edge of the neck segment (4) can be opposite the other adjacent edge in an arcuate manner to the right and / or left outer edge (18, 19) of the face mask (1).
  • the end segment (2) and the cheek segment (3) adjoin one another between the regions (7) and (9) and (8) and (9) ,
  • the face mask according to the invention preferably has an opening (10) in the area of the mouth in the cheek segment (3).
  • the oral section provided is not subject to any particular restriction and may have any suitable shape and size.
  • the opening (10) is formed as a recess.
  • the area which is provided as an opening (10) for the mouth area with a corresponding perforation (10a) with which a corresponding opening (10) can easily be formed by separating out the mask material.
  • the face mask in the lower edge region (24) of the neck segment (4) substantially comprises one or more vertical perforations (25) or cuts (25) which allow the formation of incisions in the neck segment (4) , on.
  • the vertical cuts (25) generally have a length of at least 0.5 cm, preferably at least 1.0 cm, more preferably at least 1.5 cm, more preferably at least 2.0 cm.
  • the vertical cuts (25) generally have a length of at most 3.0 cm, preferably at most 2.5 cm, more preferably at most 2.0 cm.
  • the face mask (1) according to the invention preferably has, starting from the perforation (6), one or more incisions (26) or perforations (26) which extend into the cheek segment (3) and allow the formation of incisions in the cheek segment (3). on.
  • the vertical cuts (26) generally have a length of at least 0.5 cm, preferably at least 1.0 cm, more preferably at least 1.5 cm, more preferably at least 2.0 cm.
  • the vertical cuts (26) generally have a length of at most 3.0 cm, preferably at most 2.5 cm, more preferably at most 2.0 cm.
  • the face mask (1) according to the invention preferably has, starting from the perforation (6), one or more incisions (27) or perforations (27) which extend into the neck segment (4) and allow the formation of incisions in the neck segment (4). on.
  • the vertical cuts (27) generally have a length of at least 0.5 cm, preferably at least 1.0 cm, more preferably at least 1.5 cm, more preferably at least 2.0 cm.
  • the vertical cuts (27) generally have a length of at most 3.0 cm, preferably at most 2.5 cm, more preferably at most 2.0 cm.
  • the face mask (1) according to the invention in the end segment (2) preferably starting from the edge region of the upper part of the area provided for the cover of the nose (11), which adjoins the removable regions (7, 8), in the front segment (2 ) in substantially horizontal incisions (28) or perforations (28), which allow the formation of substantially horizontal incisions in the frontal segment (2), on.
  • the horizontal incisions (28) generally have a length of at least 0.2 cm, preferably at least 0.4 cm, more preferably at least 0.6 cm, more preferably at least 0.8 cm.
  • the horizontal cuts (28) generally have a length of at most 1.2 cm, preferably at most 1.0 cm, more preferably at most 0.8 cm.
  • incisions in each case in the same lengths or in different lengths, for example in Abjokeit from their placement on the mask segments.
  • incisions are made shorter than rather incisions placed at the edge.
  • the face mask is formed as in the illustration 1 shown.
  • the reference numerals of FIG. 1 refer to the above explanations.
  • FIG. 2 shows the distance a between two lines passing through the imaginary points A, B and B 'of the face mask according to FIG FIG. 1 to run.
  • FIG. 3 shows another use of the removable segments (7, 8, 9).
  • the blank of the face mask according to the invention is designed so that with a minimum blending a total of six different segments for facial and neck treatment can be made from only one DIN A4 sheet. This ensures maximum utilization of an A4 sheet.
  • the face mask according to the invention comprises a carrier material.
  • this carrier material must be suitable for receiving liquids, since the application of the face masks according to the invention usually takes place in a moistened or pre-moistened form or a moistening is carried out in the course of the application.
  • the support material must be selected so that the masks available therefrom have sufficient stability to be converted by cutting and perforation in the geometric shape of the invention can.
  • the face masks according to the invention must have sufficient mechanical stability in order also during use or during the course of the application, in particular during separation the perforated segments, as well as when applying and modeling the individual segments on the body region to be treated, both in the dry and in the moistened state to remain dimensionally stable and in particular not to tear.
  • the carrier material is selected from the group consisting of proteins, such as. As collagen, gelatin, elastin, keratin, fibroin, albumin, with collagen, if appropriate, is also particularly preferred in admixture with other fibrillar proteins.
  • proteins such as collagen, gelatin, elastin, keratin, fibroin, albumin, with collagen, if appropriate, is also particularly preferred in admixture with other fibrillar proteins.
  • collagen-based carrier materials it is preferable to select those materials known in the art. For example, on the DE 40 28 622 or on the DE 103 50 654 directed.
  • the preferred collagen carrier materials are distinguished, in particular, by outstanding hydration properties and good absorbency, as well as by their anti-irritative and skin-soothing properties. Due to the structural similarity to human skin and tissue, collagen species found in the skin and tissues are most preferably used. These include, in particular, collagen type I, III and V. In this way, a particularly good compatibility and biocompatibility of the carrier material with the skin is achieved.
  • the carrier materials selected in this way are biodegradable in the body and can therefore be naturally degraded.
  • the collagenous carrier material is preferably derived from collagen sources from cattle, horses and pigs. Bovine collagen is very particularly preferred.
  • the carrier material may, for. B. soluble or insoluble animal or vegetable collagen such. B. fish collagen or mixtures thereof.
  • the collagen can be prepared by conventional methods, such as in DE 103 50 654 described by the Applicant, are obtained from the usual sources, such as skins or tendons. Mixtures of, for example, collagen and gelatin, or more preferably collagen and elastin, may also be used.
  • collagen materials be used, which were subjected to a crosslinking reaction. In this case, thermal crosslinking, the so-called dehydrothermal crosslinking, is preferred.
  • the crosslinking with chemical crosslinkers is possible.
  • aldehydes such as glutaraldehyde
  • Carbodiimides such as EDC
  • isocyanates Epoxides or imidazoles, wherein the epoxide from the group of chemical crosslinkers is particularly preferred.
  • the carrier material of the face mask may also be a vegetable carrier material.
  • one of the group of natural structure-forming polymers is preferably selected, preferably from the group of polysaccharides or glucosaminoglycans.
  • the natural polymers are selected from the polysaccharides.
  • Polysaccharides include, for example, homoglycans or heteroglycans, such as alginates, especially sodium alginate, carrageenan (optionally also referred to herein by the common English name "carragenan”), pectins, pullulan, tragacanth, guar gum, locust bean gum, agar-agar, gum Arabic, xanthan, pullulan, natural and modified starches, dextrans, dextrin, maltodextrins, chitosan, glucans, such as ⁇ -1,3-glucan, ⁇ -1,4-glucan, such as cellulose, mucopolysaccharides, such as hyaluronic acid, etc., or Mixtures thereof.
  • one of the above-mentioned different polymer, for. B. to select those from the group of synthetic and / or semi-synthetic and / or modified natural polymers.
  • Such synthetic, semi-synthetic or modified natural polymers include, for example, cellulose ethers, polyvinyl alcohol, polyvinylpyrrolidone, synthetic cellulose derivatives such as methylcellulose, carboxycellulose, carboxymethylcellulose, sodium carboxymethylcellulose, cellulose esters, cellulose ethers such as hydroxypropylcellulose, polyacrylic acid, Polymethacrylic acid, poly (methyl methacrylate) (PMMA), polymethacrylate (PMA), polyethylene glycols, cationized celluloses or cationized starches, etc.
  • the carrier materials can be laminated or the carrier materials can be present in the form of multilayer, interconnected layers.
  • laminates conventional materials known in the art, e.g. Fibers, nonwovens, nets, films or foils of suitable materials, e.g. Rayon, cellulose, polyethylene (PE) or polyurethane (PU) or other synthetic or semi-synthetic polymers / copolymers prepared by conventional methods, e.g. by gluing, hot lamination, crosslinking, etc. with the carrier materials in the context of the present invention can be firmly connected.
  • Such a lamination is particularly suitable for increasing the mechanical stability of the carrier materials for producing the face masks according to the invention, as well as for improving their handleability during application, especially in the moistened state.
  • the polymeric support materials according to the invention can by conventional methods, such as in the DE 103 50 654 , of the WO 04/104076 , of the WO 05/113656 or the WO 08/020066 described by the applicant.
  • the polymers of the face mask according to the invention have good biocompatibility and are in particular compatible with the skin and mucous membranes and have no toxicological effects either when used on intact skin or when introduced into one of the lower skin layers, for example in wounds which have an injury or destruction of the natural skin structure Potential. Also, the polymers to be used according to the invention do not cause any irritation effects or other incompatibility reactions when applied. They are pharmacologically completely harmless and therefore optimal suitable as polymer material for the cosmetic and pharmaceutical dermal uses according to the invention.
  • the face mask according to the invention may additionally comprise at least one active substance.
  • At least one active substance is contained in such face masks according to the invention.
  • Active ingredients include, in particular, cosmetic or therapeutic or pharmaceutical agents suitable for external use. Accordingly, such freeze-dried compositions of the invention are preferably cosmetic or therapeutic agents.
  • Cosmetic agents or agents produced using cosmetic agents in the context of the invention are essentially agents within the meaning of the Food, Commodities and Feed Code (LFGB), ie, substances or preparations of substances which are intended to be externally to humans for cleaning , Care, or to influence appearance or body odor, or to mediate the expression of olfaction, unless they are primarily intended to relieve or eliminate disease, suffering, bodily injury or pathological condition.
  • the cosmetic moldings used according to the invention are, for example, bath preparations, skin cleansing and cleansing compositions, skin care products, in particular facial skin care products, eye cosmetics, lip care products, nail care products, foot care products, hair care products, in particular shampoos, hair conditioners, hair conditioners, sunscreen agents, skin tanning agents. and brightening agents, depigmenting agents, deodorants, antiperspirants, hair removing agents, insect repellents, etc. or such agents in combination.
  • cosmetically optionally also, for example, dermatological, therapeutically active compounds include: anti-acne agents, antimicrobials, antiperspirants, astringents, deodorizing agents, depilatory agents, conditioning agents for the Skin, skin smoothing agents, skin hydration enhancers such as: As glycerol or urea, sunscreens, keratolytics, radical scavengers for free radicals, anti-seborrhea, anti-dandruff agents, antiseptic agents, agents for the treatment of signs of aging and / or modulating the differentiation and / or proliferation and / or pigmentation of the skin, vitamins such as vitamin C (ascorbic acid) and its derivatives such as glycosides such as ascorbyl glucoside or esters of ascorbic acid such as sodium or magnesium ascorbyl phosphate or ascorbyl palmitate and stearate L-ascorbic acid phosphate ester, alkali metal salts such as sodium and potassium salts of L
  • Active ingredients with irritating side effects such as alpha hydroxy acids, ⁇ -hydroxy acids, alpha-keto acids, ⁇ -keto acids, retinoids (retinol, retinal, retinoic acid), anthralines (dioxyanthranol), anthranoids, peroxides (especially benzoyl peroxide), minoxidil, lithium salts, antimetabolites , Vitamin D and its derivatives; Catechins, flavonoids, ceramides, polyunsaturated fatty acids, essential fatty acids (eg gamma-linolenic acid), enzymes, coenzymes, enzyme inhibitors, hydrating agents, skin soothing agents, detergents or foam-forming agents, and inorganic or synthetic matting fillers, or decorative materials such as pigments or dyes and particles for foundations, make-up formulations, and other agents for cosmetic embellishment and color design of the eyes, lips, face etc.
  • retinoids retinol, retinal, retinoic acid
  • plant extracts or extracted extracts or individual substances can be mentioned.
  • the plant extract is typically selected from the group consisting of solid plant extracts, liquid plant extracts, hydrophilic plant extracts, lipophilic plant extracts, individual plant ingredients; and their mixtures, such as flavonoids and their aglycans: rutin, quercetin, diosmin, hyperoside, (neo) hesperidin, hesperitin, ginkgo biloba (eg ginkoflavone glycosides), Crataegus extract (eg oligomeric procyanidins), buckwheat (eg rutin), Sophora japonica ( eg rutin), birch leaves (eg Quercetinglykoside, hyperoside and rutin), elderflower (eg rutin), lime blossom (eg.
  • Echinacea purpurea eg.
  • Alcoholic extracts fresh plant juice, pressed juice
  • Eleutherococcus senticosus alkaloids
  • Caffeine Teein, Theobromine, Rauwolfia (eg Prajmalin), Periwinkle (zBVincamin); other herbal medicines: aloe, horse chestnut (eg Aescin), garlic (eg garlic oil), pineapple (eg bromelaine), ginseng (eg ginseno-side), milk thistle fruits (eg silymarin standardized extract), butcher's root (eg ruscogenin), valerian (eg valepotriate , Tct. Valerianae), kava-kava (eg kavalactones), hop flowers (eg hop bitter substances), Extr.
  • Passi-florae gentian (eg ethanol extract), anthraquinone-containing drug extracts, eg aloin-containing aloe vera juice, pollen extract, algae extracts, licorice root extracts, Palm extract, galphimia (eg, turpentine), mistletoe (eg, aqueous-ethanol extract), phytosterols (eg, beta-sitosterol), wool flowers (eg, aqueous-alcohol extract), drosera (eg, liqueur wine extract), sea buckthorn fruits (eg, juice derived therefrom or seabuckthorn oil) , Marshmallow root, primrose root extract, fresh plant extracts from mallow, comfrey, ivy, horsetail, yarrow, ribwort (eg pressed juice), stinging nettle, celandine, parsley; Plant extracts from Norolaena lobata, Tagetes lucida, Teaoma siems,
  • the therapeutic face masks to those containing at least one pharmaceutical or therapeutic, especially dermatological active ingredient and which are intended under the Medicines Act, inter alia, to cure, alleviate or prevent diseases, disorders, body damage or pathological complaints .
  • those agents or active substances are particularly suitable for external or transdermal application, in particular in the field of wound treatment and healing as well as in the treatment of burn injuries, in particular for the initial supply of burns, preferably already as a first aid measure at the accident site , are determined.
  • those active ingredients or active ingredient compositions are also preferred which reduce posttraumatic tissue damage, the so-called afterburning and thus prevent a worsening situation occurring after the actual damage event by supplying moisture to the fresh burn wound, reducing overheating and cellular care, especially in the marginal area the wound is improved and an oxidative cell damage is prevented while calming the surrounding skin, reducing the sensation of pain and improving wound healing.
  • Active substances for such a dermal or transdermal application are in particular skin-active but also transdermal active substances. They include, for example: agents for the treatment of burn injuries, especially in primary care, such as known from the US 4870002 , of the JP 10-017480 or the US 5958420 , Agents for the treatment of skin diseases, externally applicable analgesics, e.g. Dextropropoxyphene, pentazocine, pethidine, buprenorphine; Anti-inflammatory drugs / anti-inflammatory drugs (NSAIDs), eg.
  • benzbromarone allopurinol
  • Dermatological preparations antihistamines, antibiotics, including antibacterial agents, such as colloidal silver and silver salts, antifungals, Peptidarznei für, antiviral agents, anti-inflammatory agents, antipruritic agents, anesthetizing agents, eg. Benzocaine, corticoids, acne, antiparasitic agents; externally applicable hormones; Veins therapeutics; Immunosuppresives etc. all for dermal or transdermal use.
  • antibacterial agents such as colloidal silver and silver salts, antifungals, Peptidarzneistoffe, antiviral agents, anti-inflammatory agents, antipruritic agents, anesthetizing agents, eg. Benzocaine, corticoids, acne, antiparasitic agents; externally applicable hormones; Veins therapeutics; Immunosuppresives etc. all for dermal or transdermal use.
  • Preferred therapeutic agents for dermal and transdermal application are agents for the treatment of burn injuries, especially for the acute or primary care of burn wounds, and in this context, in particular, agents with moisturizing, cooling, anesthetizing, anti-inflammatory action or mixtures thereof;
  • Agents for the treatment of skin diseases such as atopic dermatitis, atopic dermatitis, etc., and anti-herpes agents, and in particular those used in the field of wound treatment, in particular for the treatment of chronic wounds, bedsores, leg ulcers, etc., such as analgesics, eg Immunosuppressants, hormones, anesthetizing agents, antiparasitic, fungicidal or antifungal and antibacterial agents such as in particular silver-containing agents such.
  • silver nitrate silver chloride, silver iodide or other known from the prior art silver-containing wound care agents, agents to support and regulate the wound environment such as in particular electrolytes, silica, minerals and trace elements such.
  • agents to support and regulate the wound environment such as in particular electrolytes, silica, minerals and trace elements such.
  • bronchial therapeutics such as antiasthmatics, antitussives, mucolytics, etc.
  • antidiabetics such as glibenclamide, hormones, steroid hormones such as dexamethasone, cardiac glycosides such as digitoxin, cardiovascular therapeutics such.
  • Beta-blockers, antiarrhythmics, antihypertensives, calcium antagonists etc psychotropic and antidepressants such as tricyclic antidepressants (NSMRIs), serotonin reuptake inhibitors (SSRIs), norepinephrine reuptake inhibitors (NRIs), serotonin norepinephrine Recovery Inhibitors (SNRI), monoamine oxidase inhibitors (MAOIs) etc., neuroleptics, anticonvulsants or antiepileptics, hypnotics, sedatives, anesthetics, gastric and intestinal therapies, lipid lowering agents, analgesics such.
  • NSMRIs tricyclic antidepressants
  • SSRIs serotonin reuptake inhibitors
  • NRIs norepinephrine reuptake inhibitors
  • SNRI serotonin norepinephrine Recovery Inhibitors
  • MAOIs monoamine oxidase inhibitors
  • hydrocolloids especially those based on natural polymers such as polysaccharides, may also have certain therapeutic effects.
  • the preferred hydrocolloid (sodium) alginate used is antiviral to some extent, and hyaluronic acid is said to have some re-epithelializing effect and as an antioxidant and moisturizer in skin care, but they are not active ingredients in the meaning of the invention.
  • the face mask according to the invention may further comprise at least one adjuvant.
  • Adjuvants include pH adjusting agents such as buffering agents, inorganic and organic acids or bases; Fatty substances such as mineral oils such as paraffin oils or vaseline oils, silicone oils, vegetable oils such as coconut oil, sweet almond oil, apricot oil, corn oil, jojoba oil, olive oil, avocado oil, sesame oil, palm oil, eucalyptus oil, rosemary oil, lavender oil, pine oil, thyme oil, mint oil, cardamom oil, orange blossom oil, soybean oil, Bran oil, rice oil, rapeseed oil and castor oil, wheat germ oil and vitamin E isolated therefrom, evening primrose oil, plant lecithins (eg soya lecithin), sphingolipids / ceramides isolated from plants, animal oils or fats such as tallow, lanolin, butter oil, neutral oil, squalane, fatty acid esters, esters of Fatty alcohols such as triglycerides; and waxes having a melting point corresponding to skin temperature (animal
  • oils are preferred.
  • cosmetic oils as listed above, in particular triglycerides, more preferably caprylic / caproic acid triglycerides, squalane or jojoba oil are preferred.
  • the face masks according to the invention are obtainable by cutting, pre-perforating and / or perforating, punching and / or cutting of layered or sheet-shaped carrier materials as described above, in particular of those which are in the form of freeze-dried materials into the desired geometric shape according to the above-described inventive face mask and optionally provided the face mask or the individual segments with an embossing and / or a colored print.
  • the wet tensile strength of the inventively preferred support materials is preferably at least 50 mN / mm layer thickness, more preferably 100 mN / mm, even more preferably 200 mN / mm.
  • optical density refers to the quantitative unit of optical density, measured as a decadic logarithm of the ratio of transmitted light intensity to irradiated light intensity, determined using a Heiland SW Densitometer TD 03 on freeze-dried face masks with a layer thickness of 1 mm.
  • the compositions of the present invention preferably have an optical density of ⁇ 0.02, more preferably ⁇ 0.03, more preferably ⁇ 0.05, per mm of layer thickness.
  • a high optical density is advantageous, for example, for those face masks which are colored with colored printings, e.g. in the form of aesthetic form and color designs, lettering, logos or explanations should be provided.
  • Blanks can be individually packaged, which is particularly preferred in therapeutic or pharmaceutical but also in professional cosmetic application. Blanks for cosmetic use can also be present in a plurality of side by side or one above the other in contact in a suitable container or a suitable packaging.
  • the face masks according to the invention are used for external cosmetic as well as external and transdermal pharmaceutical application.
  • the external application is carried out in particular in the cosmetic application so that the various segments are separated from each other at the designated perforations before use and dry applied to the body parts to be treated and there with water or an aqueous solution containing one or more active ingredients and / or one or more adjuvants (a so-called activator solution), moistened and rehydrated.
  • activator solution a so-called activator solution
  • Another object of the present invention is a care or treatment set containing at least one face mask as described above.
  • the present invention relates to the use of a face mask (1) according to the invention for the cosmetic treatment of facial and neck skin areas.
  • the present invention also relates to a combination comprising at least one of the face masks according to the invention or their blanks and at least one aqueous solution which contains one or more active ingredients and / or at least one or more auxiliaries (a so-called activator solution) in an associated, spatial arrangement (Application package, set, kit-of-parts, etc.).
  • aqueous solution which contains one or more active ingredients and / or at least one or more auxiliaries (a so-called activator solution) in an associated, spatial arrangement (Application package, set, kit-of-parts, etc.).
  • the active substance solution may be, for example, solutions of readily volatile active ingredients and / or adjuvants which, owing to the production process, for example, should not be introduced into a freeze-dried face mask, for example certain proportions of essential oils, perfumes, etc It is also possible to include those active ingredients and / or adjuvants which have a moisturizing effect, especially in the case of the external achieve moisturizing effect, which is particularly desirable and preferred for external application to the skin, and which can not be incorporated or only in small amounts in the present invention preferred freeze-dried compositions due to this moistening effect or due to hygroscopic tendencies, since the stability possibly contained moisture-labile substances can no longer be maintained.
  • one or more of the aforementioned active ingredients and / or auxiliaries may be present in the activator solutions.
  • such drug solutions may be included in the kit-of-parts embodiments that are suitable for the rehydration and cooling of burn wounds, especially in the acute and primary care of burn injuries.
  • rehydration solutions are known from the prior art. These are u.a. also to physiological solutions or electrolyte-containing solutions, which may optionally contain other suitable active ingredients, as stated above.
  • the preferred embodiments are preferably aqueous activator or rehydration solutions, for which reason the combination in a kit-of-parts arrangement with a face mask of a hydrophilic, open-pored, absorbent carrier material according to the invention is then particularly preferred.
  • An open-pore sponge-like foam structure as it is present in particular in freeze-dried carrier materials, is particularly preferred since the carrier material of the face mask has a high absorbency and if suitable polymers are selected, for example from the group comprising collagen, alginates, hyaluronic acid and / or polyacrylates (carbomers). , ideally also has a high fluid intake and holding capacity.
  • Another important effect of this preferred application is the ability to dissipate heat simply and over a large area by creating a cooling effect through the evaporation of the liquid.
  • Cooling is not only beneficial in the treatment of burn injuries, but also in damaged skin z. As in sunburns or sports injuries or to relieve painful and unpleasant skin inflammation or to relieve side effects of irritating cosmetic treatments such. As exfoliation, laser, Fraxel or Resurfacing oppositionen. In this case, it is particularly desirable to allow the cooling effect to be sustained over a relatively long period of time, which can be achieved, in particular, by the particularly preferred hydrophilic, open-pored, absorbent carrier materials described above.
  • a hydrophobic material would not be able to absorb an aqueous drug solution.
  • the use of a hydrophobic material in combination with a hydrophobic drug solution z. B. based on fats and oils is due to the completion of the wound (the so-called occlusion) with prevention of transmission and heat dissipation disadvantageous and therefore undesirable.
  • kits-of-parts embodiments at least one of the face masks according to the invention or their blanks with more than one, mutually different solutions, which contains one or more active ingredients and / or at least one or more excipients in a belonging together , spatial arrangement (application package, set, kit-of-parts, etc.).
  • the different activator solutions are provided for rehydration of the various face mask segments and their composition is specifically tailored to the corresponding body part to be treated. This is inasmuch as the facial skin is known to be divided into different zones, such as T-zone, U-zone, etc., wherein the different zones have a different skin structure or sensitivity with correspondingly different treatment, care or protection requirement.
  • the area of the so-called T-zone which includes in particular the forehead and the nose, is usually a less sensitive and prone to skin blemishes and increased skin fat formation area, whereas, for example, the area of the cheeks is more prone to skin dryness.
  • the area under the eyes is characterized by an extreme Dünnkorutmaschine and high sensitivity with increased wrinkling. Due to the immediate proximity to the extremely sensitive mucous membranes of the eye, the application of irritant or spreading active ingredients or auxiliaries is only conditionally or even impossible.
  • the facial area has typical problem areas that require special treatment with active ingredients.
  • kit-of-parts combinations of inventive face mask on the one hand and drug solution on the other hand can provide that the two components are removed separately from the kit-of-parts arrangement and are brought together outside for further use.
  • a combination of the components within the kit-of-parts packaging, for example in chambers provided for this purpose, itself and the rehydrated composition is then supplied directly from this further cosmetic or pharmaceutical external or transdermal use. This can preferably be carried out directly by the end user.

Landscapes

  • Cosmetics (AREA)
EP10158628.7A 2010-03-31 2010-03-31 Masque facial Active EP2371237B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP10158628.7A EP2371237B1 (fr) 2010-03-31 2010-03-31 Masque facial

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP10158628.7A EP2371237B1 (fr) 2010-03-31 2010-03-31 Masque facial

Publications (2)

Publication Number Publication Date
EP2371237A1 true EP2371237A1 (fr) 2011-10-05
EP2371237B1 EP2371237B1 (fr) 2015-08-26

Family

ID=42736856

Family Applications (1)

Application Number Title Priority Date Filing Date
EP10158628.7A Active EP2371237B1 (fr) 2010-03-31 2010-03-31 Masque facial

Country Status (1)

Country Link
EP (1) EP2371237B1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10905646B2 (en) 2014-10-31 2021-02-02 Lubrizol Advanced Materials, Inc. Thermoplastic polyurethane film for delivery of active agents to skin surfaces

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2743916C1 (ru) * 2020-07-28 2021-03-01 Владимир Николаевич Школьный Маска косметическая сегментированная однократного применения
DE202022106557U1 (de) 2022-11-23 2022-12-02 Elena Berkana Netz-Gesichtsmaske

Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0063875A2 (fr) 1981-04-16 1982-11-03 MAX FACTOR & CO Masque faciale cosmétique
US4870002A (en) 1981-04-07 1989-09-26 The United States Of America As Represented By The Secretary Of The Air Force Method of prevention of oxidative injury to cells
DE4028622A1 (de) 1990-09-08 1992-03-12 Suwelack Nachf Dr Otto Verfahren zum herstellen von kollagenschwaemmen
DE4328329A1 (de) 1992-08-26 1994-03-03 Suwelack Nachf Dr Otto Gefriergetrocknete Biomatrix
US5656279A (en) 1994-02-23 1997-08-12 Bio Med Sciences, Inc. Semi-interpenetrating polymer network scar treatment sheeting, process of manufacture and useful articles thereof
JPH1017480A (ja) 1996-07-01 1998-01-20 Osaka Ship Building Co Ltd 皮膚疾患治療剤
US5958420A (en) 1997-03-13 1999-09-28 Nortrade Medical, Inc. Treatment of burns, cuts, and abrasions of the skin
WO2001076550A1 (fr) * 2000-04-10 2001-10-18 Dr. Suwelack Skin & Health Care Ag Masque constitue d'une bande dotee de deux composants partiels relies de façon amovible et procede de traitement cosmetique du visage
US20030190339A1 (en) 1997-10-14 2003-10-09 Gregory Skover Novel skin resurfacing recovery system
US20040022830A1 (en) * 2002-07-18 2004-02-05 Kenji Nakamura Face mask having excellent usability
WO2004104076A1 (fr) 2003-05-23 2004-12-02 Dr. Suwelack Skin & Health Care Ag Procedes de production de corps façonnes poreux contenant de l'alginate
DE10350654A1 (de) 2003-10-29 2005-06-02 Dr. Suwelack Skin & Health Care Ag Collagen-Träger-Wirkstoff-Zusammensetzung
WO2005113656A1 (fr) 2004-05-21 2005-12-01 Dr. Suwelack Skin & Health Care Ag Procede pour fabriquer des elements moules poreux a base d'alginate
WO2008020066A1 (fr) 2006-08-17 2008-02-21 Dr. Suwelack Skin & Health Care Ag Composition de principes actifs stabilisée

Patent Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870002A (en) 1981-04-07 1989-09-26 The United States Of America As Represented By The Secretary Of The Air Force Method of prevention of oxidative injury to cells
EP0063875A2 (fr) 1981-04-16 1982-11-03 MAX FACTOR & CO Masque faciale cosmétique
DE4028622A1 (de) 1990-09-08 1992-03-12 Suwelack Nachf Dr Otto Verfahren zum herstellen von kollagenschwaemmen
DE4328329A1 (de) 1992-08-26 1994-03-03 Suwelack Nachf Dr Otto Gefriergetrocknete Biomatrix
US5656279A (en) 1994-02-23 1997-08-12 Bio Med Sciences, Inc. Semi-interpenetrating polymer network scar treatment sheeting, process of manufacture and useful articles thereof
JPH1017480A (ja) 1996-07-01 1998-01-20 Osaka Ship Building Co Ltd 皮膚疾患治療剤
US5958420A (en) 1997-03-13 1999-09-28 Nortrade Medical, Inc. Treatment of burns, cuts, and abrasions of the skin
US20030190339A1 (en) 1997-10-14 2003-10-09 Gregory Skover Novel skin resurfacing recovery system
WO2001076550A1 (fr) * 2000-04-10 2001-10-18 Dr. Suwelack Skin & Health Care Ag Masque constitue d'une bande dotee de deux composants partiels relies de façon amovible et procede de traitement cosmetique du visage
US20040022830A1 (en) * 2002-07-18 2004-02-05 Kenji Nakamura Face mask having excellent usability
WO2004104076A1 (fr) 2003-05-23 2004-12-02 Dr. Suwelack Skin & Health Care Ag Procedes de production de corps façonnes poreux contenant de l'alginate
DE10350654A1 (de) 2003-10-29 2005-06-02 Dr. Suwelack Skin & Health Care Ag Collagen-Träger-Wirkstoff-Zusammensetzung
WO2005113656A1 (fr) 2004-05-21 2005-12-01 Dr. Suwelack Skin & Health Care Ag Procede pour fabriquer des elements moules poreux a base d'alginate
WO2008020066A1 (fr) 2006-08-17 2008-02-21 Dr. Suwelack Skin & Health Care Ag Composition de principes actifs stabilisée

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10905646B2 (en) 2014-10-31 2021-02-02 Lubrizol Advanced Materials, Inc. Thermoplastic polyurethane film for delivery of active agents to skin surfaces

Also Published As

Publication number Publication date
EP2371237B1 (fr) 2015-08-26

Similar Documents

Publication Publication Date Title
EP2394617B1 (fr) Biomatrices perforées en forme de couches
EP1749047B1 (fr) Procede pour fabriquer des elements moules poreux a base d'alginate
EP2253665B1 (fr) Composition lyophilisée
EP2218447A1 (fr) Compositions contenant des micro ou nanoparticules lipides pour l'amélioration de l'action dermique de particules solides
EP2460531B1 (fr) Collagène pour l'utilisation dans le traitement de maladies de la peau
DE10034491A1 (de) Folien-Dermatika
DE10226990A1 (de) Topisch applizierbare Mikro-Emulsionen mit binärer Phasen- und Wirkstoffdifferenzierbarkeit, deren Herstellung und deren Verwendung, insbesondere zur Versorgung der Haut mit bioverfügbarem Sauerstoff
KR20090083750A (ko) 피부 가용성 터치 필름
EP3634342A1 (fr) Coussinet en silicone comprenant des principes actifs pour les soins de la peau et contre le vieillissement de la peau
DE19911262C2 (de) Vorrichtung zur Abgabe kosmetischer Wirkstoffe
EP2371237B1 (fr) Masque facial
EP3666259A1 (fr) Compositions aqueuses capables de mousser a base de biopolymeres avec une distribution de cellulures memoire de gas flexible selon son usage
BR102019013368A2 (pt) composições e métodos para tratamento de condições da pele usando luz e cloridrato de glicosamina
KR20170079337A (ko) 피부 온도 감응형 기능성 하이드로 겔을 이용한 얼굴윤곽 개선용 패치 및 그 제조방법
US20060067996A1 (en) Preventing/treating signs of skin stress/aging by bioenergetically modifying acupuncture points of the face or neck
EP1551373B1 (fr) Utilisation d'elements moules pour une application externe
WO2009115216A1 (fr) Utilisation d'un constituant ou d'un extrait de baobab en cas de maladies de peau
DE202022106557U1 (de) Netz-Gesichtsmaske
EP2399648B1 (fr) Composition cosmétique et son utilisation
DE10248314A1 (de) Verwendung von Formkörpern zur äußeren Anwendung
DE102012014688A1 (de) Chitosan-Präparat
WO2019025733A1 (fr) Compositions et produits cosmetiques de soins de la peau

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

AX Request for extension of the european patent

Extension state: AL BA ME RS

17P Request for examination filed

Effective date: 20120307

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: MEDSKIN SOLUTIONS DR. SUWELACK AG

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20150305

INTG Intention to grant announced

Effective date: 20150311

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

INTG Intention to grant announced

Effective date: 20150709

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

Free format text: NOT ENGLISH

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 744614

Country of ref document: AT

Kind code of ref document: T

Effective date: 20150915

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

Free format text: LANGUAGE OF EP DOCUMENT: GERMAN

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 502010010138

Country of ref document: DE

REG Reference to a national code

Ref country code: CH

Ref legal event code: NV

Representative=s name: LATSCHA SCHOELLHORN PARTNER AG, CH

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150826

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150826

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150826

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20151127

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20151126

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20150826

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150826

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150826

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150826

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20151228

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20151226

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150826

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 7

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150826

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150826

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150826

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150826

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150826

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150826

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 502010010138

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150826

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20160530

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150826

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20160331

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150826

Ref country code: LU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160331

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: AT

Payment date: 20170322

Year of fee payment: 8

Ref country code: IE

Payment date: 20170323

Year of fee payment: 8

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150826

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 9

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150826

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150826

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20100331

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150826

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150826

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150826

REG Reference to a national code

Ref country code: CH

Ref legal event code: PCAR

Free format text: NEW ADDRESS: GRELLINGERSTRASSE 60, 4052 BASEL (CH)

REG Reference to a national code

Ref country code: AT

Ref legal event code: MM01

Ref document number: 744614

Country of ref document: AT

Kind code of ref document: T

Effective date: 20180331

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180331

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180331

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 20230428

Year of fee payment: 14

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20231123

REG Reference to a national code

Ref country code: DE

Ref legal event code: R082

Ref document number: 502010010138

Country of ref document: DE

Representative=s name: BOEHMERT & BOEHMERT ANWALTSPARTNERSCHAFT MBB -, DE

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20240331

Year of fee payment: 15

Ref country code: GB

Payment date: 20240322

Year of fee payment: 15

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20240319

Year of fee payment: 15